Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
NASDAQFinancialsFinancial - Capital MarketsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
1.39 → 1.43 EPS · FY ending Dec 31, 2027 · 4 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 4 to 4; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for PWP yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Maintain strong business pipeline | Perella Weinberg Partners keeps a strong business pipeline. | Improving | Business pipeline momentum declines materially over next 4 quarters | Backlog visibility into 2027 vs maintain/grow target Q3 earnings beat; 67% comp ratio target; backlog visibility into 2027; merger talks abandoned. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earningsObserved price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
PWP is an expansion-focused financial advisory business, with growth tied to talent, acquisitions, and deal activity. Its multi-year view is still developing: execution on expansion is evident, but recent performance remains weak and earnings are loss-making.
The valuation is expensive versus peers, while the priced-in assessment is tagged justified and fragility is low. The expectations gap is slightly negative, so the evidence does not point to a large buffer between expectations and fundamentals.
Near term, revenue has strengthened: Q3 revenue rose 53% year over year, and the firm has added senior talent and completed an acquisition. However, recent financial performance remains weak relative to its industry cohort, and earnings surprises have been erratic and trending down; guidance and execution remain important risks.
The multi-year thesis depends on PWP sustaining revenue growth through its talent and acquisition strategy while improving its weak financial performance. Near term, a guidance cut would be a meaningful negative, while continued strong results from sector bellwethers could support sector momentum; a shift to rate cuts is another stated risk.
Over the next one to three years, PWP’s expansion efforts provide evidence of progress, but the loss-making profile, weak relative performance, and expensive valuation leave the thesis dependent on stronger, sustained execution. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| It has a robust capital allocation strategy through acquisitions. |
| Under Pressure |
| Acquisitions fail to add value or dilute shareholder returns materially |
M&A pipeline 0 deals vs target >0 PWP abandoned $6bn merger talks with Piper Sandler; CEO sold $4.08m stock; Q3 earnings beat. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
EPS of $0.05 for 2026-Q1 | It aims for EPS of $0.05 in 2026-Q1. | Intact | EPS falls below $0.05 in 2026-Q1 | Diluted EPS: $0.21 per share FY2026-Q3; GAAP. Published target: EPS >= $0.05. The stored target says 2026-Q1; this source reports FY2026-Q3. Fiscal/calendar alignment needs review. Oct 30, 20260.21 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$1.40 → $1.43 · observed estimates
$1.04B → $1.05B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $1.40 | $1,044,252,750 | 4 / 4 |
| 2026-07-25 | $1.40 | $1,044,252,750 | 4 / 4 |
| 2026-07-26 | $1.40 | $1,044,252,750 | 4 / 4 |
| 2026-07-27 | $1.40 | $1,044,252,750 | 4 / 4 |
| 2026-07-28 | $1.40 | $1,044,252,750 | 4 / 4 |
| 2026-07-29 | $1.40 | $1,044,252,750 | 4 / 4 |
| 2026-07-30 | $1.40 | $1,044,252,750 | 4 / 4 |
| 2026-07-31 | $1.40 | $1,044,252,750 | 4 / 4 |
| 2026-08-01 | $1.40 | $1,044,252,750 | 4 / 4 |
| 2026-08-02 | $1.41 | $1,041,101,500 | 4 / 4 |
| 2026-08-03 | $1.46 | $1,042,726,500 | 4 / 4 |
| 2026-08-04 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-08-05 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-08-06 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-08-07 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-08-08 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-08-09 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-08-10 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-08-12 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-08-13 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-08-14 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-08-15 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-08-16 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-08-17 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-08-18 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-08-19 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-08-20 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-08-21 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-08-22 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-08-23 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-08-24 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-08-25 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-08-26 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-08-27 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-08-28 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-08-29 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-08-30 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-08-31 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-09-01 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-09-02 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-09-03 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-09-04 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-09-05 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-09-06 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-09-07 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-09-08 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-09-09 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-09-10 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-09-11 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-09-12 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-09-13 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-09-14 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-09-15 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-09-16 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-09-17 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-09-18 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-09-19 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-09-20 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-09-21 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-09-22 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-09-23 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-09-24 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-09-25 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-09-26 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-09-27 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-09-28 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-09-29 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-09-30 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-10-01 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-10-02 | $1.46 | $1,052,226,500 | 4 / 4 |
| 2026-10-03 | $1.46 | $1,051,438,249 | 4 / 4 |
| 2026-10-04 | $1.46 | $1,051,438,249 | 4 / 4 |
| 2026-10-05 | $1.39 | $1,020,613,250 | 4 / 4 |
| 2026-10-06 | $1.39 | $1,020,613,250 | 4 / 4 |
| 2026-10-07 | $1.39 | $1,020,638,250 | 4 / 4 |
| 2026-10-08 | $1.39 | $1,020,638,250 | 4 / 4 |
| 2026-10-09 | $1.34 | $1,006,888,250 | 4 / 4 |
| 2026-10-10 | $1.34 | $1,007,538,250 | 4 / 4 |
| 2026-10-11 | $1.34 | $1,007,538,250 | 4 / 4 |
| 2026-10-12 | $1.37 | $1,007,538,250 | 4 / 4 |
| 2026-10-13 | $1.37 | $1,007,538,250 | 4 / 4 |
| 2026-10-14 | $1.37 | $1,008,173,750 | 4 / 4 |
| 2026-10-15 | $1.37 | $1,008,173,750 | 4 / 4 |
| 2026-10-16 | $1.37 | $1,008,173,750 | 4 / 4 |
| 2026-10-17 | $1.37 | $1,008,173,750 | 4 / 4 |
| 2026-10-18 | $1.37 | $1,008,173,750 | 4 / 4 |
| 2026-10-19 | $1.37 | $1,008,173,750 | 4 / 4 |
| 2026-10-20 | $1.37 | $1,008,173,750 | 4 / 4 |
| 2026-10-21 | $1.37 | $1,008,173,750 | 4 / 4 |
| 2026-10-22 | $1.37 | $1,008,173,750 | 4 / 4 |
| 2026-10-23 | $1.37 | $1,008,173,750 | 4 / 4 |
| 2026-10-24 | $1.37 | $1,008,173,750 | 4 / 4 |
| 2026-10-25 | $1.37 | $1,008,173,750 | 4 / 4 |
| 2026-10-26 | $1.37 | $1,008,173,750 | 4 / 4 |
| 2026-10-27 | $1.37 | $1,008,173,750 | 4 / 4 |
| 2026-10-28 | $1.37 | $1,008,173,750 | 4 / 4 |
| 2026-10-29 | $1.37 | $1,008,173,750 | 4 / 4 |
| 2026-10-30 | $1.40 | $1,020,247,750 | 4 / 4 |
| 2026-10-31 | $1.43 | $1,048,872,750 | 4 / 4 |
| 2026-11-01 | $1.43 | $1,048,872,750 | 4 / 4 |
| 2026-11-02 | $1.43 | $1,048,872,750 | 4 / 4 |
| 2026-11-03 | $1.43 | $1,048,872,750 | 4 / 4 |
| 2026-11-04 | $1.43 | $1,048,872,750 | 4 / 4 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 3 Buy / Strong Buy · 0 Hold · 1 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 1 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
2 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.